Gene therapy in gastroenterology.

Recent Advances in Hemophilia Gene Therapy

Heterogeneous loss of function mutations at F8 and F9 genes causes X-linked recessive bleeding disorders, hemophilia A (HA) and hemophilia B (HB), respectively. HA is clinically indistinguishable from HB and accounts for more than 80% of hemophilia cases; the former affects 1/5000 and the latter 1/25000 male births worldwide. In Iran, it is estimated that around 4300 HA and 900 HB patients are ...

Corticotropin releasing factor receptor antagonists: potential future therapy in gastroenterology?

New corticotropin releasing factor (CRF) antagonists in irritable bowel disease (IBS) warrant testing, and CRF1 receptors may be a promising target for the treatment of IBS.

Optimizing Ibd Therapy in Dogs & Cats: Gastroenterology Evidence-based Observations

Introduction Arguably, idiopathic inflammatory bowel disease is the most common histologic diagnosis in dogs and cats with histories of chronic vomiting and diarrhea. Uncontrolled studies and anecdotal reports from many clinicians and medical centers report a favorable response of IBD to several different forms of medical therapy. Unfortunately, the efficacy of these different forms of therapy ...

ژن درمانی Gene Therapy

Gastroenterology

This book is one of a series of handbooks commissioned by the British Nuclear Medicine Society to act as a guide to Clinicians interested in the clinical use of radioactive tracers. The book is designed to discuss the potential applications of radioactive trace methods to clinical problem solving. No one would dispute the attraction of a series of this kind and after the choice of topic, the mo...